Singh, Asheesh, and Parul Singh. “TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS”. Journal of Drug Delivery and Therapeutics 6, no. 5 (September 12, 2016): 97–102. Accessed April 30, 2026. https://www.jddtonline.info/index.php/jddt/article/view/1303.